Aequus Pharmaceuticals Inc. (TSXV:AQS)

Aequus Pharmaceuticals Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.01	0.05	0.17	0.25	2.39	1.72
Short-Term Investments	-	-	0.04	0.04	0.04	-
Cash & Short-Term Investments	0.01	0.05	0.22	0.29	2.44	1.72
Cash Growth	-80.27%	-76.64%	-27.02%	-87.91%	41.75%	254.77%
Accounts Receivable	0.17	0.06	0.03	0.31	0.94	0.78
Inventory	0	0.04	0.12	0.09	0.14	0.12
Other Current Assets	0.01	0.14	0.07	0.2	0.08	0.15
Total Current Assets	0.2	0.28	0.44	0.9	3.59	2.77
Net Property, Plant & Equipment	-	0.52	0.65	0.79	0.24	0.37
Long-Term Investments	-	-	-	-	0.51	-
Total Assets	0.2	0.8	1.09	1.69	4.35	3.13
Accounts Payable	1.02	0.54	0.27	0.09	0.16	0.16
Accrued Expenses	0.04	0.1	0.04	0.2	0.22	0.08
Short-Term Debt	6.03	6.03	4.37	2	-	-
Current Portion of Long-Term Debt	-	-	-	-	1.93	1.95
Current Portion of Leases	-	0.12	0.11	0.09	0.15	0.15
Total Current Liabilities	7.09	6.8	4.8	2.38	2.46	0.38
Long-Term Debt	-	-	-	-	0.03	0.02
Long-Term Leases	-	0.46	0.58	0.69	0.08	0.2
Total Long-Term Liabilities	-	0.46	0.58	0.69	0.1	0.22
Total Liabilities	7.09	7.26	5.38	3.07	2.56	2.56
Common Stock	23.99	23.99	23.99	23.99	23.99	21.17
Additional Paid-in Capital	4.42	4.42	4.4	4.35	4.31	4.1
Retained Earnings	-35.3	-34.86	-32.68	-29.72	-26.51	-24.7
Shareholders' Equity	-6.89	-6.45	-4.29	-1.38	1.79	0.57
Total Liabilities & Equity	0.2	0.8	1.09	1.69	4.35	3.13
Total Debt	6.03	6.61	5.06	2.78	2.18	2.32
Net Cash (Debt)	-6.02	-6.56	-4.85	-2.49	0.26	-0.6
Net Cash Per Share	-0.04	-0.05	-0.04	-0.02	-	-0.01
Book Value	-6.89	-6.45	-4.29	-1.38	1.79	0.57
Book Value Per Share	-0.05	-0.05	-0.03	-0.01	-	0.01
Tangible Book Value	-6.89	-6.45	-4.29	-1.38	1.79	0.57
Tangible Book Value Per Share	-0.05	-0.05	-0.03	-0.01	-	0.01

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.